# PureTech Founded Entity Seaport Therapeutics Announces Pricing of Upsized Initial Public Offering
Canonical URL: https://biopharmsignal.com/news/PRTC/puretech-founded-entity-seaport-therapeutics-announces-pricing-of-upsized-initial-public-offering
Ticker: PRTC
Company: PureTech Health
Source: PureTech Health
Published: 2026-05-01 06:00 EST
Original Source URL: https://investors.puretechhealth.com
## Summary

RNS Number: 7401C PureTech Health PLC 01 May 2026   1 May 2026 PureTech Health plc   PureTech Founded Entity Seaport Therapeutics Announces Pricing of Upsized Initial Public Offering   PureTech Health plc  (Nasdaq: PRTC, LSE: PRTC) (" PureTech " or the "Company"), a hub-and-spoke biotherapeutic

## Article Body
RNS Number: 7401C PureTech Health PLC 01 May 2026   1 May 2026 PureTech Health plc   PureTech Founded Entity Seaport Therapeutics Announces Pricing of Upsized Initial Public Offering   PureTech Health plc  (Nasdaq: PRTC, LSE: PRTC) (" PureTech " or the "Company"), a hub-and-spoke biotherapeutics
## Recent Company News
- 2026-05-13 11:00 EST — [PureTech to Showcase Deupirfenidone Program at the American Thoracic Society International Conference](https://biopharmsignal.com/news/PRTC/puretech-to-showcase-deupirfenidone-program-at-the-american-thoracic-society-international-conference) — Source: PureTech Health
- 2026-05-01 06:00 EST — [PureTech Founded Entity Seaport Therapeutics Announces Pricing of Upsized Initial Public Offering](https://biopharmsignal.com/news/PRTC/puretech-founded-entity-seaport-therapeutics-announces-pricing-of-upsized-initial-public-offering) — Source: PureTech Health
- 2026-04-29 06:01 EST — [PureTech Announces Annual Results for Year Ended December 31, 2025](https://biopharmsignal.com/news/PRTC/puretech-announces-annual-results-for-year-ended-december-31-2025) — Source: PureTech Health
- 2026-04-29 06:00 EST — [PureTech Announces Intention to Voluntarily Delist American Depositary Shares from Nasdaq and Concentrate Trading on the London Stock Exchange](https://biopharmsignal.com/news/PRTC/puretech-announces-intention-to-voluntarily-delist-american-depositary-shares-from-nasdaq-and-concentrate-trading-on-the-london-stock-exchange) — Source: PureTech Health
- 2026-04-27 11:05 EST — [PureTech Founded Entity Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of Directors](https://biopharmsignal.com/news/PRTC/puretech-founded-entity-seaport-therapeutics-adds-intra-cellular-therapies-founder-and-ceo-dr-sharon-mates-to-its-board-of-directors) — Source: PureTech Health
## Related News
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)
- 2026-07-21 11:30 EST — ABEO — [Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®](https://biopharmsignal.com/news/ABEO/cincinnati-children-s-activated-as-the-seventh-qualified-treatment-center-for-ze-8382d043)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)